Quarterly report · Q2
4109.TEDINET S100PL5J
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥37.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥58.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥56.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥58.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥13.9bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥45.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥42.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥42.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥595m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥94m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥242.27 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.83 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥422.97 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.45 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.79 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥194m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥77m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥116m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥9m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥17.3bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥283m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥21.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥19.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥21.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥19.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥186m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥82m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥104m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥8m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥15.6bn |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥125m |
| jpcrp040300-q2r_E00805-000High Purity Chemicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.5bn |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥69m |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥69m |
| jpcrp040300-q2r_E00805-000Medicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥332m |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E00805-000Transportationreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥373m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥19.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥18.0bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 548
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 104000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1707000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 15756000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 3803000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00805-000MedicalReportableSegmentsMember | 69000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 19629000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 186000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 19816000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 2523000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 373000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00805-000MedicalReportableSegmentsMember | -332000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 2564000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 8000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2572000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 17263000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 2277000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 19540000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 77000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 19618000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 1693000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 1693000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 116000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1809000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 17263000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 3970000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 21234000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 194000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 21428000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00805-000HighPurityChemicalReportableSegmentsMember | 1958000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00805-000TransportationReportableSegmentsMember | 283000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 2241000000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2250000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第80期第２四半期(自 2022年７月１日 至 2022年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ステラケミファ株式会社 | |
| Company name in english cover page | FilingDateInstant | STELLA CHEMIFA CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 橋本 亜希 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市中央区伏見町四丁目１番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | (06)4707－1512 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役執行役員経理部長 中島 康彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市中央区伏見町四丁目１番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | (06)4707－1512 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役執行役員経理部長 中島 康彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00805 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |